What is the severity of mitral stenosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Severity Classification of Mitral Stenosis

Mitral stenosis is classified as severe when the mitral valve area (MVA) is ≤1.0 cm², mean transmitral gradient is >10 mmHg, and pulmonary artery systolic pressure (PASP) is >50 mmHg. 1

Diagnostic Parameters for Severity Classification

The severity of mitral stenosis is determined using three key parameters:

Severity MVA (cm²) Mean Gradient (mmHg) PASP (mmHg)
Mild >1.5 <5 <30
Moderate 1.0-1.5 5-10 30-50
Severe <1.0 >10 >50

Hemodynamic Assessment

The hemodynamic severity is best characterized by:

  1. Planimetered mitral valve area - Direct measurement of the valve orifice
  2. Calculated mitral valve area from the diastolic pressure half-time (PHT)
    • MVA (cm²) = 220/PHT (ms)
    • PHT ≥150 ms suggests severe stenosis 2

The mean pressure gradient is highly dependent on:

  • Transvalvular flow
  • Diastolic filling period
  • Heart rate variations

Dynamic Assessment of Severity

Exercise or stress echocardiography provides valuable information about the hemodynamic significance of mitral stenosis:

  • MS is diagnosed as severe if the mean gradient is >15 mmHg on exertion or >18 mmHg during dobutamine infusion 2
  • PASP >60 mmHg on exertion is another marker of hemodynamically significant MS 2

Important Clinical Considerations

  • A noncompliant mitral valve may be moderately stenotic at rest but hemodynamically severely stenotic during stress, as it fails to open further to accommodate increased flow 2
  • Mean gradient <10 mmHg does not exclude severe MS, particularly in patients with:
    • Atrial fibrillation
    • Enlarged left atrium
    • Impaired left ventricular diastolic function 1

Discrepancies in Guidelines

While most guidelines agree on the definition of severe MS as MVA ≤1.0 cm², there are some variations:

  • The European Society of Cardiology (ESC) and American College of Cardiology/American Heart Association (ACC/AHA) guidelines define severe MS as MVA ≤1.5 cm² for intervention purposes 2
  • The diastolic pressure half-time threshold of ≥150 ms is used inconsistently across guidelines 2

Intervention Considerations

Intervention is typically considered for:

  • Symptomatic patients with severe MS (MVA ≤1.0 cm²)
  • Moderate MS (MVA 1.0-1.5 cm²) with evidence of hemodynamic significance:
    • Mean gradient >15 mmHg during exercise
    • PASP >60 mmHg during exercise 2

Conclusion

When evaluating mitral stenosis severity, it is essential to integrate multiple parameters including MVA, mean gradient, and PASP. In cases of discrepancy between resting measurements, stress echocardiography provides crucial information about the hemodynamic significance of the stenosis, which better reflects the true functional severity of the condition.

References

Guideline

Mitral Stenosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.